India's Shilpa Medicare up on clearing Australian inspection
17/10/2023 10:02
** Shares of Shilpa Medicare SHME.NS rise as much as 2.44%
to 346.7 rupees
** Co says its Jadcherla manufacturing facility cleared Good
Manufacturing Practice (GMP) inspection from TGA, Australia
** Inspection will allow company to register and market its
products in Australia and other markets which recognize
Australian GMP
** Over 213,000 shares traded as of 2:20 p.m. IST, nearly
equal to its 30-day avg
** Stock up 1.1% at 2:30 p.m. IST, taking YTD gains to ~22%
(Reporting by Nishit Navin)
((nishit.navin@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026